Eribaxaban
Eribaxaban (PD348292) is an oral, small-molecule factor Xa inhibitor used in research for preventing and treating venous thromboembolism. It serves as a key pharmacological tool in hematology and thrombosis research, enabling both in vitro enzymatic assays and in vivo preclinical models of thrombosis.
Product Specifications
CAS Number
536748-46-6
Product Name Alternative
PD 348292, PD0348292, PD-0348292, PD 0348292, PD348292, PD-348292, FactorXa, Factor Xa, Eribaxaban
Field of Research
Metabolism Research
Purity
98.99% (May vary between batches)
Solubility
DMSO:100 mg/mL (206.22 mM) ;10% DMSO+40% PEG300+5% Tween-80+45% Saline:2 mg/mL (4.12 mM)
Smiles
C (NC1=C (F) C=C (C=C1) N2C (=O) C=CC=C2) (=O) [C@@H]3N (C (NC4=CC=C (Cl) C=C4) =O) C[C@H] (OC) C3
Molecular Formula
C24H22ClFN4O4
Molecular Weight
484.91
Storage Conditions
-20°C
Notes
For research use only.
Available Sizes
Frequently Asked Questions
More Discoveries
Explore Other Products
Browse additional items from our catalog
IMSAHUCD83HB15ECAF488100 100 Tests
Anti Human CD83 Flow Cytometry Monoclonal Clone HB15E AF488 Ready To Use 100 Tests
Sign In for Pricing
View Details 
MBS7201279-01 48 Well
Chicken Mediator of RNA polymerase II transcription subunit 16 (MED16) ELISA Kit
Sign In for Pricing
View Details